Fortress Biotech, Inc. FBIO

Company Overview

Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing pharmaceutical and biotechnology products through a diversified portfolio structure. The company operates primarily in the biotechnology and specialty pharmaceutical industries, with activities spanning drug development, product commercialization, and strategic healthcare investments. Fortress Biotech generates value through majority-owned and partner companies that advance therapies targeting oncology, rare diseases, dermatology, infectious diseases, and gene therapy. Revenue is derived from product sales, licensing arrangements, royalties, collaborative agreements, milestone payments, and equity interests in subsidiaries and partner entities.

The company was founded in 2006 and is headquartered in Bay Harbor Islands, Florida. Fortress Biotech evolved from a healthcare-focused acquisition and development platform into a holding company model designed to incubate and finance multiple biotechnology programs simultaneously. Its structure allows subsidiary companies to operate with relative independence while leveraging centralized capital access, management expertise, and regulatory support. The company’s strategic positioning is tied to its diversified pipeline model, which reduces dependence on a single product candidate while providing exposure to multiple therapeutic areas and commercialization pathways.